Motobayashi Mitsuo, Fukuyama Tetsuhiro, Nakayama Yoshiko, Sano Kenji, Noda Shunsuke, Hidaka Yoshihiko, Amano Yoshiro, Ikeda Shu-Ichi, Koike Kenichi, Inaba Yuji
Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Pediatr Int. 2014 Jun;56(3):429-32. doi: 10.1111/ped.12291.
Fulminant Wilson's disease (WD) is life-threatening. The revised WD prognostic index (RWPI) has been used to predict the severity of the disease, with a score ≥11 indicating fatal outcome without liver transplantation (LTx). We here report the case of a 10-year-old female patient with fulminant WD (RWPI, 16) who recovered fully after plasma exchange and continuous hemodiafiltration, followed by treatment with copper chelate agents. To the best of our knowledge, there have been five fulminant WD patients with RWPI ≥ 11 including the present patient, in whom LTx was not done. Based on the therapeutic modalities in these five cases, non-surgical treatment (blood purification and copper chelate agents) may be able to avoid LTx in fulminant WD even with very high RWPI, although preparation for LTx is necessary.
暴发性威尔逊病(WD)危及生命。修订后的WD预后指数(RWPI)已用于预测疾病的严重程度,评分≥11表明在无肝移植(LTx)的情况下预后不良。我们在此报告一例10岁女性暴发性WD患者(RWPI为16),该患者在进行血浆置换和持续血液透析滤过,随后接受铜螯合剂治疗后完全康复。据我们所知,包括本患者在内,已有5例RWPI≥11的暴发性WD患者未进行肝移植。基于这5例患者的治疗方式,非手术治疗(血液净化和铜螯合剂)或许能够避免对RWPI非常高的暴发性WD患者进行肝移植,尽管进行肝移植准备是必要的。